[
1. Gopal S, Joseph R, Santhosh VC, Kumar VV, Joseph S, Shete AR. Prevalence of gingival overgrowth induced by antihypertensive drugs: A hospital-based study. J Indian Soc Periodontol. 2015;19(3):308-11.10.4103/0972-124X.153483452011726229273
]Search in Google Scholar
[
2. Trackman PC, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res. 2015; 94 (4): 540-546.10.1177/0022034515571265448521725680368
]Search in Google Scholar
[
3. Goriuc A, Foia LG, Minea B, Luchian AI, Surdu AE, Toma V, Costuleanu M, Mârţu I. Drug-induced gingival hyperplasia - experimental model. Rom J Morphol Embryol. 2017; 58 (4): 1371-1376.
]Search in Google Scholar
[
4. Dongari-Bagtzoglou A; Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol. 2004;75(10):1424-31.10.1902/jop.2004.75.10.142429539069
]Search in Google Scholar
[
5. Tonsekar P, Tonsekar V. Calcium-Channel-Blocker- Influenced Gingival Enlargement: A Conundrum Demystified. Oral. 2021;1(3):236-49.10.3390/oral1030023
]Search in Google Scholar
[
6. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Perio. 1992; 19: 1–11.10.1111/j.1600-051X.1992.tb01140.x1732303
]Search in Google Scholar
[
7. Tamargo J, Ruilope LM. Investigational calcium channel blockers for the treatment of hypertension. Expert Opin Investig Drugs. 2016;25(11):1295-1309.10.1080/13543784.2016.124176427696904
]Search in Google Scholar
[
8. McKeever RG, Hamilton RJ. Calcium Channel Blockers. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
]Search in Google Scholar
[
9. Lin Y, Ma L. Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: A systematic review and meta-analysis. Medicine (Baltimore). 2018;97(48):e13152.10.1097/MD.0000000000013152628318730508892
]Search in Google Scholar
[
10. Wang AL, Iadecola C, Wang G. New generations of dihydropyridines for treatment of hypertension. J Geriatr Cardiol. 2017;14(1):67-72.
]Search in Google Scholar
[
11. Volpe M. Calcium Channel Blockers for the Clinical Management of Hypertension. High Blood Press Cardiovasc Prev. 2018;25(1):1-3.10.1007/s40292-017-0233-029022231
]Search in Google Scholar
[
12. Wing LMH. Calcium channel antagonists. Aust Prescr 1997;20:5-8.10.18773/austprescr.1997.004
]Search in Google Scholar
[
13. Russell RP. Side effects of calcium channel blockers. Hypertension. 1988;11(3 Pt 2):II42-4.10.1161/01.HYP.11.3_Pt_2.II423280492
]Search in Google Scholar
[
14. Dustan HP. Calcium channel blockers. Potential medical benefits and side effects. Hypertension. 1989;13(5 Suppl):I137-4010.1161/01.HYP.13.5_Suppl.I137
]Search in Google Scholar
[
15. Bharti V, Bansal C. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. J Indian Soc Periodontol. 2013; 17 (2): 182-187.10.4103/0972-124X.113066371374823869123
]Search in Google Scholar
[
16. Tungare S, Paranjpe AG. Drug Induced Gingival Overgrowt. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
]Search in Google Scholar
[
17. Tahamtan S, Shirban F, Bagherniya M, Johnston TP, Sahebkar A. The effects of statins on dental and oral health: A review of preclinical and clinical studies. J Transl Med. 2020; 18: 1–42.10.1186/s12967-020-02326-8713295532252793
]Search in Google Scholar
[
18. Quach H, Ray-Chaudhuri A. Calcium channel blocker induced gingival enlargement following implant placement in a fibula free flap reconstruction of the mandible: A case report. Int J Implant Dent. 2020; 6: 1–5.10.1186/s40729-020-00242-6743148332808200
]Search in Google Scholar
[
19. Asif SM, Shaik N, Barthunia B, Kaleem SM, Zakirulla M, Kota MZ, Baig FAH. Nifedipine induced gingival enlargement in an edentulous patient: a case report with one year follow up. BMC Oral Health. 2018;18(1):227.10.1186/s12903-018-0690-4630715730587167
]Search in Google Scholar
[
20. Casetta I, Granieri E, Desiderá M, Monetti VC, Tola MR, Paolino E, Govoni V, Calura G. Phenytoin-induced gingival overgrowth: a community-based cross-sectional study in Ferrara, Italy. Neuroepidemiology. 1997;16(6):296-303.10.1159/0001097009430129
]Search in Google Scholar
[
21. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999;70(1):63-7.10.1902/jop.1999.70.1.6310052772
]Search in Google Scholar
[
22. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol. 1992;19(5):311-4.10.1111/j.1600-051X.1992.tb00650.x
]Search in Google Scholar
[
23. Fattore L, Stablein M, Bredfeldt G, Semla T, Moran M, Doherty-Greenberg JM. Gingival hyperplasia: a side effect of nifedipine and diltiazem. Spec Care Dentist. 1991;11(3):107-9.10.1111/j.1754-4505.1991.tb00828.x1887359
]Search in Google Scholar
[
24. Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol. 1995;66(7):572-8.10.1902/jop.1995.66.7.5727562349
]Search in Google Scholar
[
25. Bajkovec L, Mrzljak A, Likic R, Alajbeg I. Drug-induced gingival overgrowth in cardiovascular patients. World J Cardiol. 2021;13(4):68-75.10.4330/wjc.v13.i4.68806952133968305
]Search in Google Scholar
[
26. Ishida H, Kondoh T, Kataoka M, Nishikawa S, Nakagawa T, Morisaki I, Kido J, Oka T, Nagata T. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol. 1995;66(5):345-50.10.1902/jop.1995.66.5.3457623253
]Search in Google Scholar
[
27. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000;27(4):217-23.10.1034/j.1600-051x.2000.027004217.x10783833
]Search in Google Scholar
[
28. Pasupuleti MK, Musalaiah SV, Nagasree M, Kumar PA. Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease. Avicenna J Med. 2013;3(3):68-72.10.4103/2231-0770.118462381878224251234
]Search in Google Scholar
[
29. Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol. 1988;15(1):1-16.10.1111/j.1600-051X.1988.tb01549.x3276739
]Search in Google Scholar
[
30. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol. 1992;19(1):1-11.10.1111/j.1600-051X.1992.tb01140.x1732303
]Search in Google Scholar
[
31. Aldemir NM, Begenik H, Emre H, Erdur FM, Soyoral Y. Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report. Afr Health Sci. 2012;12(4):576-8.
]Search in Google Scholar
[
32. Tejnani A, Gandevivala A, Bhanushali D, Gourkhede S. Combined treatment for a combined enlargement. J Indian Soc Periodontol. 2014;18(4):516-9.10.4103/0972-124X.138747415859825210271
]Search in Google Scholar
[
33. Gaur S, Agnihotri R. Is dental plaque the only etiological factor in Amlodipine induced gingival overgrowth? A systematic review of evidence. J Clin Exp Dent. 2018;10(6):e610-e61910.4317/jced.54715600509429930781
]Search in Google Scholar
[
34. Takeuchi RE, Matsumoto HI, Akimoto YO, Fujii AK. The inhibitory action of amlodipine for TNF-α-induced apoptosis in cultured human gingival fibroblasts. Oral Ther. Pharmacol. 2012;31:45-52.
]Search in Google Scholar
[
35. Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. J Hum Hypertens. 2014;28(1):10-4.10.1038/jhh.2013.4723739159
]Search in Google Scholar
[
36. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6.10.1902/annals.1999.4.1.110863370
]Search in Google Scholar
[
37. Daley TD, Wysocki GP. Cyclosporine therapy. Its significance to the periodontist. J Periodontol. 1984;55(12):708-12.10.1902/jop.1984.55.12.7086335173
]Search in Google Scholar
[
38. Ellis JS, Monkman SC, Seymour RA, Idle JR. Determination of nifedipine in gingival crevicular fluid: a capillary gas chromatographic method for nifedipine in microlitre volumes of biological fluid. J Chromatogr. 1993;621(1):95-10110.1016/0378-4347(93)80081-E8308093
]Search in Google Scholar
[
39. Bharti V, Bansal C. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. J Indian Soc Periodontol. 2013;17(2):182-7.10.4103/0972-124X.113066371374823869123
]Search in Google Scholar
[
40. Meisel P, Giebel J, Kunert-Keil C, Dazert P, Kroemer HK, Kocher T. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists. Clin Pharmacol Ther. 2006;79(1):62-71.10.1016/j.clpt.2005.09.00816413242
]Search in Google Scholar
[
41. Uzel MI, Kantarci A, Hong HH, Uygur C, Sheff MC, Firatli E, Trackman PC. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol. 2001;72(7):921–931.10.1902/jop.2001.72.7.92111495141
]Search in Google Scholar
[
42. Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. J Periodontol 1985; 56(4):211–215.10.1902/jop.1985.56.4.2113858503
]Search in Google Scholar
[
43. Ramírez-Rámiz A, Brunet-LLobet L, Lahor-Soler E, Miranda-Rius J. On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth. Open Dent J. 2017;11:420-435.10.2174/1874210601711010420556401628868093
]Search in Google Scholar
[
44. Castro LA, Elias LS, Oton-Leite AF, de Spíndula-Filho JV, Leles CR, Batista AC, Mendonça EF. Long-term effects of nifedipine on human gingival epithelium: a histopathological and immunohistochemical study. J Oral Sci. 2010;52(1):55-62.10.2334/josnusd.52.5520339233
]Search in Google Scholar
[
45. Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis. 2015;21(1):e51-61.10.1111/odi.12264524188824893951
]Search in Google Scholar
[
46. Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Wilkinson R, Ilde JR. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the rôle of HLA phenotype. J Clin Periodontol. 1996;23(7):628-34.10.1111/j.1600-051X.1996.tb00586.x
]Search in Google Scholar
[
47. Pernu HE, Knuuttila ML. Macrophages and lymphocyte subpopulations in nifedipine and cyclosporin A associated human gingival overgrowth. J Periodontol 2001;72(2):160-6.10.1902/jop.2001.72.2.16011288788
]Search in Google Scholar
[
48. Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila ML. Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication. J Periodontol 2002;73(11):1323-30.10.1902/jop.2002.73.11.132312479637
]Search in Google Scholar
[
49. Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fifibroblasts by recombinant human interleukin- 6. J Invest Dermatol 1991; 97: 686–689.10.1111/1523-1747.ep124839711940439
]Search in Google Scholar
[
50. Csiszar A, Wiebe C, Larjava H, Häkkinen L. Distinctive molecular composition of human gingival interdental papilla. J Periodontol 2007;78(2): 304-14.10.1902/jop.2007.06016517274720
]Search in Google Scholar
[
51. Walsh P, Häkkinen L, Pernu H, Knuuttila M, Larjava H. Expression of fibronectin-binding integrins in gingival epithelium in drug-induced gingival overgrowth. J Periodontal Res 2007; 42(2): 144-51.10.1111/j.1600-0765.2006.00927.x17305873
]Search in Google Scholar
[
52. Lu HK, Tseng CC, Lee YH, Li CL, Wang LF. Flutamide inhibits nifedipine- and interleukin-1 beta induced collagen overproduction in gingival fibroblasts. J Periodontal Res 2010; 45: 451-457.10.1111/j.1600-0765.2009.01255.x
]Search in Google Scholar
[
53. Sooriyamoorthy M, Gower DB, Eley BM. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990; 25(1): 25-30.10.1111/j.1600-0765.1990.tb01204.x2137169
]Search in Google Scholar
[
54. Steele RM, Schuna AA, SchreiberRT. Calcium antagonist- induced gingival hyperplasia. Ann Intern Med 1994;120:663-4.10.7326/0003-4819-120-8-199404150-000068135450
]Search in Google Scholar
[
55. Chin YT, Tu HP, Lin CY, Kuo PJ, Chiu HC, Liu SH, Lee SY, Fu E. Antioxidants protect against gingival overgrowth induced by cyclosporine A. J Periodontal Res. 2021;56(2):397-407.10.1111/jre.1283233448057
]Search in Google Scholar
[
56. Miranda J, Brunet L, Roset P, Farré M, Mendieta C. Reliability of two measurement indices for gingival enlargement. J Periodontal Res. 2012;47(6):776-82.10.1111/j.1600-0765.2012.01495.x22897219
]Search in Google Scholar
[
57. Marshall RI, Bartold PM. A clinical review of druginduced gingival overgrowths. Aust Dent J. 1999;44(4):219-32.10.1111/j.1834-7819.1999.tb00224.x10687229
]Search in Google Scholar
[
58. Lafzi A, Farahani RM, Shoja MA. Amlodipine-induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal. 2006;11(6):E480-2.
]Search in Google Scholar
[
59. Aldemir NM, Begenik H, Emre H, Erdur FM, Soyoral Y. Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report. Afr Health Sci. 2012;12(4):576-8.10.4314/ahs.v12i4.30
]Search in Google Scholar
[
60. Torpet LA, Kragelund C, Reibel J, Nauntofte B. Oral adverse drug reactions to cardiovascular drugs. Critical reviews in oral biology & medicine. 2004;15(1):28-46.10.1177/15441113040150010414761898
]Search in Google Scholar
[
61. Quenel L, Keribin P, Giran G, Tessier MH, Lesclous P. Amlodipine-induced gingival enlargement: A case report. J Stomatol Oral Maxillofac Surg. 2020;121(3):308-311.10.1016/j.jormas.2019.04.01431055091
]Search in Google Scholar
[
62. Camargo PM, Melnick PR, Pirih FQ, Lagos R, Takei HH. Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontol 2000. 2001;27:131-8.10.1034/j.1600-0757.2001.027001131.x11551304
]Search in Google Scholar
[
63. Harel-Raviv M, Eckler M, Lalani K, Raviv E, Gornitsky M. Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 1995;79(6):715-22.10.1016/S1079-2104(05)80306-3
]Search in Google Scholar
[
64. Hall EE. Prevention and treatment considerations in patients with drug-induced gingival enlargement. Curr Opin Periodontol. 1997;4:59-63.
]Search in Google Scholar
[
65. Thompson AL, Herman WW, Konzelman J, Collins MA. Treating patients with drug-induced gingival overgrowth. J Dent Hyg. 2004;78(4):12.
]Search in Google Scholar
[
66. Dannewitz B, Krieger JK, Simon I, Dreyhaupt J, Staehle HJ, Eickholz P. Full-mouth disinfection as a nonsurgical treatment approach for drug-induced gingival overgrowth: a series of 11 cases. Int J Periodontics Restorative Dent. 2010;30(1):63-71.
]Search in Google Scholar
[
67. Dongari A, McDonnell HT, Langlais RP. Drug-induced gingival overgrowth. Oral Surg Oral Med Oral Pathol. 1993;76(4):543-8.10.1016/0030-4220(93)90027-28233439
]Search in Google Scholar
[
68. Pejčić AS, Kesić LG, Živković VD, Obradović RR, Petrović MS, Mirković DS. Gingival overgrowth induced by nifedipine: Gingiva and drugs. Acta stomatologica Naissi. 2011;27(64):1104-9.10.5937/asn1164104P
]Search in Google Scholar
[
69. Mavrogiannis M, Ellis JS, Seymour RA, Thomason JM. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth. J Clin Periodontol. 2006;33(9):677-82.10.1111/j.1600-051X.2006.00968.x16856895
]Search in Google Scholar
[
70. Ilgenli T, Atilla G, Baylas H. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol. 1999;70(9):967-72.10.1902/jop.1999.70.9.96710505798
]Search in Google Scholar
[
71. Ciancio SG, Bartz NW Jr, Lauciello FR. Cyclosporineinduced gingival hyperplasia and chlorhexidine: a case report. Int J Periodontics Restorative Dent. 1991;11(3):241-5.
]Search in Google Scholar
[
72. Alims.gov.rs. 2021. ALIMS. [online] Available at: <https://www.alims.gov.rs/> [Accessed 22 September 2021].
]Search in Google Scholar
[
73. Ustaoğlu G, Erdal E, Karaş Z. Influence of different antihypertensive drugs on gingival overgrowth: A crosssectional study in a Turkish population. Oral Dis. 2021;27(5):1313-9.10.1111/odi.1365532991012
]Search in Google Scholar